ubde12b-2520071015.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 12b-25
 
NOTIFICATION OF LATE FILING
 
 (Check One) [ ] Form 10-K and Form 10-KSB [ ] Form 20-F  [ ] Form 11-K 
                         [X] Form 10-Q and Form 10-QSB [ ] Form N-SAR 
 
For Period Ended: August 31, 2007
 
                                             [ ] Transition Report on Form 10-K     
                                             [ ] Transition Report on Form 20-F     
                                             [ ] Transition Report on Form 11-K     
                                             [ ] Transition Report on Form 10-Q     
                                             [ ] Transition Report on Form N-SAR     
                                             For the Transition Period Ended:                                                 
 
Read Attached Instruction Sheet Before Preparing Form. Please Print or Type. 
 
Nothing in this form shall be construed to imply that the Commission has 
verified any information contained herein.     
 
If the notification relates to a portion of the filing checked above, 
identify the Item(s) to which the notification relates:   N/A 
 
PART 1
REGISTRANT INFORMATION
 
Full Name of Registrant:                        US BIODEFENSE, INC.   
 
Former Name if Applicable:         
                                                                   Address of Principal Executive Office
 
                                                                   Street and Number:    375 South 6th Avenue 
                                           City, State and Zip Code:    City of Industry, California 91746 


PART II
RULES 12B-25(b) AND (c)
 
If the subject report could not be filed without unreasonable effort or 
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the 
following should be completed. (Check box if appropriate) 
 
[X]                 (a)    The reasons described in reasonable detail in Part III of 
        this form could not be eliminated without unreasonable 
        effort or expense; 
 
[X]                 (b)    The subject annual report, semi-annual report, transition 
        report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or 
        portion thereof, will be filed on or before the fifteenth 
        calendar day following the prescribed due date; or the 
        subject quarterly report or transition report on Form 10-Q, 
        or portion thereof will be filed on or before the fifth 
        calendar day following the prescribed due date; and 
 
[ ]                 (c)    The accountant's statement or other exhibit required by 
        Rule 12b-25(c) has been attached if applicable. 
 
PART III
NARRATIVE
 
State below in reasonable detail why the Form 10-K, 20-F, 11-K, 10-Q, 10D, N- 
SAR, N-CSR or the transition report or portion thereof, could not be filed 
within the prescribed time period. 
 
The Registrant is unable to timely file its Quarterly Report on Form 10-QSB 
for  the period ended August 31, 2007 because the Registrant’s principal 
independent registered public accounting firm requires additional time to 
review the financial statements prepared by the Registrant. The Registrant 
represents that its Form 10-QSB will be filed within the period specified by 
Rule 12b-25(b).     
 
PART IV
OTHER INFORMATION
 
(1)                Name and telephone number of person to contact in regard to this 
                notification 

David Chin   (626)   961-0562
(Name)   (Area Code)   (Telephone Number)

(2)          Have all other periodic reports required under Section 13 or 15(d) 
          of the Securities Exchange Act of 1934  or Section 30 of the 
          Investment Company Act of 1940 during the preceding 12 months (or 
          for such shorter period that the registrant was required to file 
          such reports) been filed? [X] Yes [ ]  No 
 
(3)          Is it anticipated that any significant change in results of 
          operations from the corresponding period for the last fiscal year 
          will be reflected by the earnings statements to be included in the 
          subject report or portion thereof? [ ]  Yes [X] No 


US Biodefense, Inc.
(Name of Registrant as Specified in Charter)
 
                   Has caused this notification to be signed on its behalf  by  the 
undersigned hereunto duly authorized.     
 
                                    Date: October 15, 2007     
                                                                                By: /s/ David Chin   
                                                                                Name:   David Chin   
                                                                                Title:  President